Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06653426 · ClinicalTrials.gov registry record · NA
The NaBu Effect on Menstruation in Women
A NA study of Menstrual Symptoms, sponsored by Magdy Milad, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06653426 is a NA study of Menstrual Symptoms that is actively recruiting participants, run by Magdy Milad, MD. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06653426, a NA study of Menstrual Symptoms, is actively recruiting participants, sponsored by Magdy Milad, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effect of once-daily Sodium butyrate (NaBu) on menstrual symptoms in women. The investigators posit that the use of NaBu will reduce menstrual symptoms after taking NaBu for 12 weeks.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Sodium Butyrate (NaBu)
Study Locations (1)
Illinois
- Northwestern University - Northwestern Medicine, Lavin Family Pavilion - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2025-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06653426
The ClinicalTrials.gov registry entry for NCT06653426 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Magdy Milad, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Menstrual Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Sodium Butyrate (NaBu) is the first listed.
NCT06653426 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06653426 about?
NCT06653426 is a clinical study titled "The NaBu Effect on Menstruation in Women". The purpose of this study is to evaluate the effect of once-daily Sodium butyrate (NaBu) on menstrual symptoms in women. The investigators posit that the use of NaBu will reduce menstrual symptoms after taking NaBu for 12 weeks.
What is the current status of trial NCT06653426?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-10-01. Estimated completion is 2025-10.
What conditions does trial NCT06653426 study?
This clinical trial studies the following conditions: Menstrual Symptoms.
What interventions are being tested in trial NCT06653426?
The interventions under investigation include: Sodium Butyrate (NaBu) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06653426?
This trial is sponsored by Magdy Milad, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06653426 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.